AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL)

CUSIP: G29687103

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares, nominal value $0.01 per share
Shares outstanding
95,992,895
Total 13F shares
73,357,625
Share change
-5,976,998
Total reported value
$1,580,599,280
Put/Call ratio
45%
Price per share
$21.55
Number of holders
204
Value change
-$27,117,037
Number of buys
110
Number of sells
120

Quarterly Holders Quick Answers

What is CUSIP G29687103?
CUSIP G29687103 identifies AVDL - AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) as of Q4 2025

As of 31 Dec 2025, AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL) was held by 204 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 73,357,625 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GENDELL JEFFREY L, Weiss Asset Management LP, TIG Advisors, LLC, TUDOR INVESTMENT CORP ET AL, FIL Ltd, Vivo Capital, LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 204 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.